In order to evaluate whether the combined expression of RANTES and IL-6 is able to induce a more aggressive tumor phenotype, we analyzed the migratory and invasive ability of MCF-7RANTES+IL6 and MDA-MB-231RANTES+IL6 cell lines. The gene discussed is CCL5; the disease is neoplasm.